Wyeth to cut jobs at Irish subsidiary
Wyeth Medica, an Irish subsidiary of US drugmaker Wyeth, plans to cut 250 jobs at its manufacturing plant in Newbridge, County Kildare, according to media reports.
Archives for October 15, 2008
Charles River opens preclinical centre in Shanghai
Charles River Laboratories has opened a new preclinical development facility in Shanghai, China which, the firm says, will act as a centre of excellence and help strengthen its position in the global outsourcing market.
Gerresheimer’s Q3 buoyed up by drug sector focus
Gerresheimer’s decision to concentrate on the pharmaceutical and life science sectors and sell-off non-core divisions appears to be paying dividends judging by a 14 per cent jump in third quarter operating profit.
Tepnel expands genetic services portfolio
Tepnel Life Sciences has expanded its pharmaceutical services offering by becoming the UK’s first genetic analysis services provider to use Illumina’s next-generation iScan system.
Synthetic glycerine is back (but never really went away)!
The relentless commoditisation of glycerine ingredients prompted Dow Chemicals to all but exit the sector a few years back, but now the company says it is seeing a resurgence for its flagship synthetic glycerine brand.
Merck’s Durham facility on road to completion
Merck & Co has completed start-up activities at its vaccine manufacturing plant in Durham, North Carolina, which is intended to further the company’s ambitions in the sector.
New software for simplifying clinical trials
Perceptive Informatics’ TrialWorks software has been upgraded to ease the uploading of information onto the ClinicalTrials.gov website.